Toby Maurer, MD, professor at University of California, San Francisco, discusses the clinical pearls of inflammatory vulvovaginal conditions and treatment.
Contemporary OB/GYN:
What are some of the clinical pearls of vulvovaginal dermatological conditions discusses at Symposia Medicus?
Toby Maurer, MD:
One of the most important things that I like to discuss with the audience is what is normal, and so, reviewing the normal anatomy of the vulvovaginal area. This really I think is helpful for patients who often come in worrying about conditions that may or may not apply. They may not understand what the normal anatomy is and what is pathologic. Some of the conditions I discuss of course include things like warts in various growth on the vulvovaginal area, but also the inflammatory diseases to include things like lichen sclerosus, lichen planus. These are conditions that are easily missed by many clinicians. In addition, I review contact dermatitis. Contact dermatitis has been a very big problem that we've encountered in our patients.
Contemporary OB/GYN:
Are there any clinical pearls for management that clinicians can take home with them?
Maurer:
Yeah, one of the biggest pearls I have is that we in dermatology approach some of these inflammatory diseases using steroids, but class 1 steroids. We've all been taught in medical school training that you should never use these potent topical steroids in the vulvovaginal area and certainly not for long duration. There is some truth to that. But I have found that clobetaso, which is a class 1 steroid, probably is not used enough. Vaginas in the vulvovaginal area are quite resistant to topical steroids. And whatever people have, it either works with club aid as well or it doesn't, and that can give you a lot of information as to what direction your diagnosis goes.
Buprenorphine use in pregnancy linked to decreased fetal breathing movements
May 18th 2024According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Identifying gaps in syphilis treatment and prenatal care among pregnant individuals
May 17th 2024Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.
Read More